quinfamide has been researched along with Amebiasis, Intestinal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, DM; Carlson, JA; Mount, EM; Siggins, J; Slighter, RG; Yarinsky, A | 1 |
| Bermúdez-Ruiz, H; Guevara-Ortigoza, MDP; Islas-Solares, E; Lezama-Guzmán, HR; Sosa-López, FA; Zamudio-Tiburcio, Á | 1 |
| Nájera Ruano, S; Olaeta Elizalde, R; Pérez Huacuja, R | 1 |
1 trial(s) available for quinfamide and Amebiasis, Intestinal
| Article | Year |
|---|---|
[Comparison of quinfamide vs etofamide in the Mexican population with intestinal amebiasis].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Amebicides; Child; Child, Preschool; Dysentery, Amebic; Humans; Infant; Mexico; Middle Aged; Quinolines | 1996 |
2 other study(ies) available for quinfamide and Amebiasis, Intestinal
| Article | Year |
|---|---|
1-(Dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol esters. New potent antiamebic agents.
Topics: Amebicides; Animals; Cecum; Cricetinae; Dysentery, Amebic; Female; Hydroxyquinolines | 1979 |
[Breaking paradigms. Intestinal microbiota transplantation: Preliminar report].
Topics: Adult; Aged; Aged, 80 and over; Anxiety; Celiac Disease; Colon; Comorbidity; Contraindications, Drug; Diarrhea; Diverticulosis, Colonic; Dysentery, Amebic; Esophagitis; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Hernia, Hiatal; Humans; Irritable Bowel Syndrome; Jejunum; Malabsorption Syndromes; Male; Metronidazole; Pilot Projects; Quinolines | 2017 |